6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride
C27H29Cl3N4O5S — CID 146056904
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride
6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride (PubChem CID 146056904) has the molecular formula C27H29Cl3N4O5S and a molecular weight of 627.98 g/mol. Its IUPAC name is 6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride.
Molecular Properties
| Compound Name | 6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride |
|---|---|
| PubChem CID | 146056904 |
| Molecular Formula | C27H29Cl3N4O5S |
| Molecular Weight | 627.98 g/mol |
| Exact Mass | 626.09 |
| IUPAC Name | 6-(benzenesulfonamido)-2-[4-(2-methoxyphenyl)piperazin-1-yl]quinoline-4-carboxylic acid;trihydrochloride |
| SMILES | COc1ccccc1N1CCN(c2cc(C(=O)O)c3cc(NS(=O)(=O)c4ccccc4)ccc3n2)CC1.Cl.Cl.Cl |
| InChI | InChI=1S/C27H26N4O5S.3ClH/c1-36-25-10-6-5-9-24(25)30-13-15-31(16-14-30)26-18-22(27(32)33)21-17-19(11-12-23(21)28-26)29-37(34,35)20-7-3-2-4-8-20;;;/h2-12,17-18,29H,13-16H2,1H3,(H,32,33);3*1H |
| InChIKey | FMZGGRHYRCYOJP-UHFFFAOYSA-N |
| XLogP | 5.33 |
| TPSA | 112.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 627.98 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146056904 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.